Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications
- PMID: 22003423
- PMCID: PMC3188826
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications
Abstract
Abuse of drugs by pregnant women both in the United States and worldwide has raised many questions regarding the effects of prenatal drug exposure on the developing fetus and subsequent child outcomes. Studies using the neurobehavioral teratology model have been undertaken to determine specific prenatal drug effects on cognitive and behavioral development. Here we summarize the findings of studies that have investigated the developmental effects of prenatal exposure to tobacco, marijuana, stimulants, and opiates. These studies consider the timing and amount of prenatal exposure; other drug exposures; maternal characteristics; and other health, nutritional, and environmental factors. We review treatment options for pregnant, substance-dependent women and therapeutic interventions for exposed children.
Figures
Comment in
-
Response: how to use a window of opportunity.Addict Sci Clin Pract. 2011 Jul;6(1):71-2. Addict Sci Clin Pract. 2011. PMID: 22003424 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical